Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction

Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology

(2012) Jolien W. Roos-Hesselink et al.   EUROPEAN HEART JOURNAL

Management of Thyroid Dysfunction during Pregnancy and Postpartum: An Endocrine Society Clinical Practice Guideline

(2012) Leslie De Groot et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study

(2012) Kasper Meidahl Petersen et al.   BMJ Open

Pregnancy issues in scleroderma

(2011) Merav Lidar et al.   AUTOIMMUNITY REVIEWS

How to manage hypertension in pregnancy effectively

(2011) Laura A. Magee et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

ESC Guidelines on the management of cardiovascular diseases during pregnancy: The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)

(2011) et al.   EUROPEAN HEART JOURNAL

Effect of Maternal Heart Disease on Fetal Growth

(2011) Emily Gelson et al.   OBSTETRICS AND GYNECOLOGY

Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy

(2010) Robert L. Davis et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY